Marques, B.L.; Lirio, P.H.C.; Vicente, M.A.; Unzueta-Larrinaga, P.; Urigüen, L.; Campos, A.C.
Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review. Pharmaceuticals 2025, 18, 1817.
https://doi.org/10.3390/ph18121817
AMA Style
Marques BL, Lirio PHC, Vicente MA, Unzueta-Larrinaga P, Urigüen L, Campos AC.
Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review. Pharmaceuticals. 2025; 18(12):1817.
https://doi.org/10.3390/ph18121817
Chicago/Turabian Style
Marques, Bruno L., Pedro H. C. Lirio, Maria A. Vicente, Paula Unzueta-Larrinaga, Leyre Urigüen, and Alline C. Campos.
2025. "Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review" Pharmaceuticals 18, no. 12: 1817.
https://doi.org/10.3390/ph18121817
APA Style
Marques, B. L., Lirio, P. H. C., Vicente, M. A., Unzueta-Larrinaga, P., Urigüen, L., & Campos, A. C.
(2025). Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review. Pharmaceuticals, 18(12), 1817.
https://doi.org/10.3390/ph18121817